Brief: China NT Pharma Group Co Posts FY Loss Attributable Rmb957.7 Mln
29/03/2019 16:18
March 29 (Reuters) - China NT Pharma Group Co Ltd 1011.HK :
* FY LOSS ATTRIBUTABLE RMB957.7 MILLION VERSUS PROFIT OF
RMB165.2
MILLION
* FY REVENUE FROM CONTINUING OPERATIONS RMB571.5 MILLION
VERSUS
RMB604.8 MILLION
Source text for Eikon: ID:nHKS4Pdqjn
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma Co
See all newsBrief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY
Brief: China NT Pharma Makes Application For Resumption Of Trading On Feb 11
Brief: HKEX Says Trading In Shares Of China NT Pharma Group Company Halted
Brief: China Nt Pharma Group Says To Issue Bonds In Aggregate Principal Amount Of HK$65 Million